Pharmaceutical - Antibiotics and Infectious diseases


Popular Filters

201 to 210 of 210 results

Inconclusive Ph III results for Pfizer’s Vfend and Eraxis combo in fungal infections


There was disappointing news for global drugs behemoth Pfizer (NYSE: PFE) last Friday, when the company…

Antibiotics and Infectious diseasesEraxisPfizerPharmaceuticalResearchVfend

More news from EMA/CHMP September meeting


Following its meetings last week, the European Medicines Agency’s Committee for Medicinal Products…

Anti-viralsAntibiotics and Infectious diseasesAstellas PharmaCelgeneDificidDificlirEuropeEvipleraGilead SciencesOncologyPharmaceuticalRegulationRevlimidUCBVimpat

Astellas get EU approval for Vibativ for nosocomial pneumonia caused by MRSA


The European Commission has granted marketing authorization for Japanese drug major Astellas’ (TYO:…

Antibiotics and Infectious diseasesAstellas PharmaEuropePharmaceuticalRegulationTheravanceVibativ

Optimer/Cubist’s Dificid poised to challenge Vancocin usage in C. difficile treatment; report


Less than half of surveyed infectious disease (ID) specialists and only 6% of surveyed internists demonstrated…

Antibiotics and Infectious diseasesCubist PharmaceuticalsDificidMarkets & MarketingNorth AmericaOptimer PharmaceuticalsPharmaceuticalVancocin

EU launches development and cooperation projects with South Africa, including AIDS and TB


European Development Commissioner Andris Piebalgs is visiting South Africa from September 13 to 16 to…

Anti-viralsAntibiotics and Infectious diseasesEuropeFinancialHealthcarePharmaceuticalRest of the World

GlaxoSmithKline partners with BARDA to develop new class of antibiotic; amends deal with Anacor


The US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority…

Anacor PharmaceuticalAntibiotics and Infectious diseasesFinancialGlaxoSmithKlineLicensingPharmaceuticalResearchTropical diseases

Majority of US surveyed MCOs will consider reimbursing novel OPAT agents; report


According to surveyed physicians in the USA, the use of out-patient parenteral antibiotic therapy (OPAT)…

Antibiotics and Infectious diseasesCubicinCubist PharmaceuticalsForest LaboratoriesIvanzMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalTeflaroTheravanceVibativ

Bayer makes moxifloxacin available to help WHO TB program in China


Bayer HealthCare, a unit of Germany’s Bayer AG (BAY: DE), has agreed to support the World Health…

Antibiotics and Infectious diseasesAsia-PacificBayerMarkets & MarketingMoxifloxacinPharmaceutical

US FDA warns high-dose of Pfizer’s Diflucan during pregnancy may cause birth defects


The US Food and Drug Administration has warned that treatment with chronic, high doses (400-800mg/day)…

Antibiotics and Infectious diseasesDiflucanNorth AmericaPfizerPharmaceuticalRegulation

201 to 210 of 210 results

Back to top